Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2009
11/18/2009EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP2117523A1 Inhibitors of akt activity
11/18/2009EP1858836B1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/18/2009EP1638961B1 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009EP1397357B9 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/18/2009EP1280781B1 5-ht 7 receptor antagonists
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009EP1184379B1 Chromene compound
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009CN101583600A Acetylene derivatives as stearoyl CoA desaturase inhibitors
11/18/2009CN101580523A Novel chemical substance having activity for morphogenesis and growth promotion
11/18/2009CN101580501A Synthetic method of 3-(substituted dihydro-isoindolone-2-group)-2,6-dioxopiperidine and intermediate thereof
11/18/2009CN101580493A Poly-substituted miazines compound, preparation method and application thereof
11/18/2009CN101580465A Substituted phenyl keto enols as pesticides and herbicides
11/18/2009CN100560585C New benzimidazole derivative
11/18/2009CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/17/2009US7619100 Physiologically active substances
11/17/2009US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7618988 Use of substituted aminomethyl chromans
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618968 Aryl triazines as LPAAT-β inhibitors and uses thereof
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009CA2422925C .delta.1-pyrrolines used as pesticides
11/17/2009CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2372691C Antifungal ethers
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/17/2009CA2206794C Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
11/12/2009WO2009137714A2 Forms of lapatinib ditosylate and processes for preparation thereof
11/12/2009WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009WO2009137338A1 Pyrazole compounds as ccr1 antagonists
11/12/2009WO2009115874A3 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
11/12/2009WO2009077500A3 Azolylmethyloxiranes, use thereof and agents containing the same
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281327 Process for the preparation of olmesartan medoxomil
11/12/2009US20090281321 Exo- and diastereo- selective syntheses of himbacine analogs
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281161 Organic Compounds
11/12/2009US20090281158 Prodrugs of cc-1065 analogs
11/12/2009US20090281138 Bis-(Sulfonylamino) Derivatives in Therapy 066
11/12/2009US20090281130 Quinazoline derivatives
11/12/2009US20090281117 1-{[2-(2,4-Difluorophenyl)-1-(3-ethoxyphenyl)-1H-imidazol-4-yl]carbonyl}-4-(2-naphthyl)piperazine, useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes
11/12/2009US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281062 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/12/2009US20090280086 Methods and compositions for treating hepatitis c virus
11/12/2009US20090280083 Compounds for the Treatment of Hepatitis C
11/12/2009CA2722811A1 Pyrazole compounds as ccr1 antagonists
11/12/2009CA2722606A1 Urea compounds as gamma secretase modulators
11/11/2009EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
11/11/2009EP2116242A1 New pharmaceutical composition
11/11/2009EP2114927A1 Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8 -di fluorochroman- s -yl ) -1, 3-dihydroimidazole-2-thione
11/11/2009EP2114926A1 Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1, 3-dihydroimidazole-2-thione
11/11/2009EP2114917A2 Pyrrole compounds
11/11/2009EP2114904A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
11/11/2009EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines
11/11/2009EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009EP1492487B1 Mitotic kinesin inhibitors
11/11/2009EP1477186B1 Antipruritics
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009CN101578281A Synthesis of selected stereoisomers of certain substituted alcohols
11/11/2009CN101578280A Benzoquinazole derivatives
11/11/2009CN101578278A Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
11/11/2009CN101578277A 5-substituted isoindoline compounds
11/11/2009CN101578272A 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
11/11/2009CN101578262A Radiolabelling via fluorination of aziridines
11/11/2009CN101578261A Heteroaryl-substituted serine amides
11/11/2009CN101575334A Extension type bimaleimide containing phenolphthalein structural chain and preparation method thereof
11/11/2009CN101575333A Quinazoline derivatives and medical application thereof
11/11/2009CN101575332A Diazacyclo propenyl-contained non-natural nucleoside, preparation method and applications thereof
11/11/2009CN101575331A Preparation method of 5'-((5-methoxyl-2-phenyl indole-1-yl) methylene)-2'-oxo-3'-tetrahydrofurfuryl
11/11/2009CN101575312A Substituted phenyl keto enols as pesticides and herbicides
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558725C Quinazoline derivatives as antiproliferative agents
11/11/2009CN100558715C Protein kinase inhibitors
11/11/2009CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615648 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
11/10/2009US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 694